PT Bio Farma (Persero)
Company typeState-owned PT
IndustryPharmaceuticals
PredecessorPasteur Institute of Indonesia (1890–1960)
Founded6 August 1890 (1890-08-06) as Parc-vaccinogène
HeadquartersBandung, Indonesia
ProductsVaccine
OwnersGovernment of Indonesia
Subsidiaries
Websitewww.biofarma.co.id/en/

PT Bio Farma (Persero) is an Indonesian state-owned enterprise based in Bandung, West Java and the only local vaccine manufacturer in Indonesia,[2] which produces vaccines and sera to support immunization in Indonesia and other countries.[3] Bio Farma vaccine produced vaccines against measles, polio, hepatitis B, and pentavalent vaccine.[2] Bio Farma has supplied vaccines to multiple countries through UNICEF, PAHO and other organizations.[4] Since 2020, it also serves as the holding company for listed state-owned enterprises Kimia Farma and Indofarma.[5]

History

Vaccine vials in Bio Farma, 2017

Bio Farma's history began during the Dutch East Indies period, when the colonial government founded Parc-vaccinogène (State Vaccine Development Agency) on 6 August 1890. The agency occupied a building in Weltevreden – Batavia, which is now Gatot Soebroto Army Hospital. Since its inception, Parc-vaccinogène focused on eliminating infectious diseases, which leads to its cooperation with Pasteur Institute. Eventually, the agency was renamed to Parc-vaccinogène en Instituut Pasteur in 1895.[3]

During the administration of J.P. van Limburg Stirum, Hendrik Tillema recommended to move the capital of Dutch East Indies to Bandung due to its natural conditions and hilly terrain, making it easier to defend. The idea was gradually accepted and began to be implemented by the Dutch colonial government in early 1920s after it was supported by Prof. J. Klopper, Rector of Technische Hogeschool te Bandoeng at the time. Government and private offices along with other agencies began moving to Bandung, including the foreign trade office, salvation army, government bodies and 's Lands Koepok Inrichting en het Instituut Pasteur, which stayed in Bandung until the present day.[6] The agency has experienced several changes in name and legal entity, which are as follows:[7]

Main Building of Bio Farma (2005)

References

  1. ^ a b Lane, EJ (21 October 2019). "Bio Farma becomes the controlling shareholder of KAEF an INAF". IDN Financials. Retrieved 23 December 2019.
  2. ^ a b Hadisoemarto, PF; Reich, MR; Castro, MC (2016). "Introduction of pentavalent vaccine in Indonesia: a policy analysis". Health Policy and Planning. 31 (8). Oxford University Press: 1079–1088. doi:10.1093/heapol/czw038. PMC 5013783. PMID 27107293.
  3. ^ a b "Bio Farma". kementerian BUMN. Retrieved 23 December 2019.
  4. ^ "Bio Farma profile". June 11, 2017. Archived from the original on August 23, 2017. Retrieved June 11, 2017.
  5. ^ Fajar, Taufik (2020-02-04). "Bio Farma Jadi Induk Holding BUMN Farmasi". Okezone (in Indonesian). Archived from the original on 2020-02-05. Retrieved 2021-09-04.
  6. ^ Reitsma, S.A.; Hoogland, W.H. (1921). Gids van Bandoeng en Omstreken. N.V. Mij. Vorkink. p. 98.
  7. ^ "Sejarah dan Perkembangan PT Bio Farma (Persero)" (PDF). June 12, 2017. Archived (PDF) from the original on February 6, 2018.

External links

International Network of Pasteur Institutes
Authority control databases
Categories